Clinical implication of morning blood pressure surge in hypertension.

Utility of ambulatory blood pressure monitoring in children and adolescents. Pediatr Nephrol (2006) 0.90

Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag (2011) 0.89

Morning hypertension and night non-dipping in patients with diabetes and chronic kidney disease. Hypertens Res (2015) 0.83

Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke. Stroke (2014) 0.81

The applicability of home blood pressure measurement in clinical practice: a review of literature. Vasc Health Risk Manag (2007) 0.80

An Emerging Role for Understanding Orthostatic Hyp'er'tension in the Cardiorenal Syndrome. Cardiorenal Med (2011) 0.77

World Congress on the insulin resistance syndrome, 2009: cellular mechanisms of insulin resistance. Diabetes Care (2010) 0.75

Awakening Blood Pressure Rise in a Patient with Spinal Cord Injury. Am J Case Rep (2016) 0.75

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (2004) 11.95

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56

Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72

Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation (2005) 8.11

Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation (2003) 7.68

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet (2002) 7.11

Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation (2008) 5.87

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res (2009) 5.24

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83

Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol (2008) 4.78

Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14

Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 3.19

Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension (2008) 2.96

Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58

Masked hypertension. Hypertension (2002) 2.57

Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension (2012) 2.53

Anatomic properties of myocardial bridge predisposing to myocardial infarction. Circulation (2009) 2.48

Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension (2011) 2.39

Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension (2010) 2.37

Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens (2008) 2.31

The Japanese Society of Hypertension Guidelines for Self-monitoring of Blood Pressure at Home (Second Edition). Hypertens Res (2012) 2.23

Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease. Circ J (2010) 2.13

The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med (2007) 2.08

Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Am J Hypertens (2007) 2.06

Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad. Eur Heart J (2008) 2.04

Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension (2009) 2.01

Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J (2009) 2.01

Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med (2008) 2.00

Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep (2008) 1.98

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood (2011) 1.91

Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens (2008) 1.91

Consistency of blood pressure differences between the left and right arms. Arch Intern Med (2007) 1.89

Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res (2012) 1.79

Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension. J Hypertens (2008) 1.78

Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res (2008) 1.78

Socioeconomic and psychosocial factors mediate race differences in nocturnal blood pressure dipping. Am J Hypertens (2009) 1.75

Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial. J Hypertens (2011) 1.75

Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation (2005) 1.67

Racism and ambulatory blood pressure in a community sample. Psychosom Med (2007) 1.64

Identification of mechanically induced genes in human monocytic cells by DNA microarrays. J Hypertens (2002) 1.61

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood (2009) 1.60

Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med (2003) 1.60

Sustained blood pressure increase after an acute stressor: the effects of the 11 September 2001 attack on the New York City World Trade Center. J Hypertens (2005) 1.58

Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension (2009) 1.57

Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens (2009) 1.57

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial. J Hypertens (2014) 1.56

Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Am J Hypertens (2005) 1.55

Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysis. Hypertension (2008) 1.54

Association between the morning-evening difference in home blood pressure and cardiac damage in untreated hypertensive patients. J Hypertens (2009) 1.53

Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens (2010) 1.52

Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker. Am J Hypertens (2010) 1.51

Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. Am J Hypertens (2009) 1.50

Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study. Cardiovasc Drugs Ther (2011) 1.46

A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study. Hypertens Res (2009) 1.46

Effect of doxazosin on the left ventricular structure and function in morning hypertensive patients: the Japan Morning Surge 1 study. J Hypertens (2008) 1.45

Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res (2003) 1.45

An increased visceral-subcutaneous adipose tissue ratio is associated with difficult-to-treat hypertension in men. J Hypertens (2010) 1.44

Association between morning blood pressure surge and cardiovascular remodeling in treated elderly hypertensive subjects. Am J Hypertens (2009) 1.44

Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens (2012) 1.41

Sleep-predominant lowering of ambulatory blood pressure by bedtime inhalation of a novel muscarinic M3 receptor antagonist: a new "bronchoantihypertensive" strategy targeting the lung in hypertension with chronic obstructive pulmonary disease. Hypertens Res (2008) 1.41

Cognitive dysfunction and physical disability are associated with mortality in extremely elderly patients. Hypertens Res (2008) 1.41

A new technique for detecting sleep apnea-related "midnight" surge of blood pressure. Hypertens Res (2006) 1.39

One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-. Circ J (2011) 1.39

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2008) 1.37

Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens (2012) 1.35

U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol (2002) 1.35

Genome-wide histone methylation profile for heart failure. Genes Cells (2008) 1.34

Assessment of the white-coat effect. J Hypertens (2006) 1.31

Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke (2008) 1.29

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2009) 1.28

Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res (2006) 1.27

Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens (2003) 1.27

Greater impact of coexistence of hypertension and diabetes on silent cerebral infarcts. Stroke (2003) 1.26

Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res (2003) 1.25

The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med (2008) 1.24

Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects. Hypertens Res (2004) 1.24

Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health And Nutrition Examination Survey. J Hypertens (2010) 1.23

Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study. Hypertens Res (2012) 1.22

Lifestyle modification and blood pressure control: is the glass half full or half empty? JAMA (2003) 1.20

Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res (2007) 1.18

Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens (2011) 1.17

Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am J Hypertens (2009) 1.17

Anxiety and outcome expectations predict the white-coat effect. Blood Press Monit (2005) 1.15

Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylation. Biochem Biophys Res Commun (2009) 1.12

Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens (Greenwich) (2007) 1.11

Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb (2010) 1.11

Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int J Cardiol (2005) 1.10

Hypertension treatment guidelines. J Clin Hypertens (Greenwich) (2004) 1.08

Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res (2004) 1.08

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol (2011) 1.07

Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis (2002) 1.06

Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause (2007) 1.06